Active	Status	Sponsor type	Region	Phase	Filter
1 Active 5 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
CBP501 / CanBas
NCT04953962: Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer	Completed	2	36	US	CBP501 (16), CBP501, CBP501 (25), Cisplatin, CDDP, Nivolumab, Opdivo	CanBas Co. Ltd.	Pancreatic Cancer Stage IV	04/23	04/23
felezonexor (CBS9106) / Menarini
No trials found
IDO/TDO dual inhibitor / Shizuoka Prefectural University, CanBas
No trials found